People Inc (PPLI) shareholders
Close on Nov 12, 2026Market cap $3.24BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 8,966,333 | 11.20% | 13G (passive) | May 31, 2024 |
| Helikon Investments Limited Joint filing with Federico Riggio (11.44%) | 7,857,290 | 11.44% | 13G (passive) amendment | Sep 30, 2026 |
| Barry Diller | 6,593,155 | 8.90% | 13D (active) amendment | Jun 22, 2026 |
| Aristeia Capital, L.L.C. | 5,702,459 | 7.96% | 13G (passive) | Dec 31, 2025 |
| Jennifer Stier Joint filing with HighSage Ventures LLC (6.60%) | 5,394,779 | 7.90% | 13D (active) | Sep 25, 2026 |
| Stier Jennifer Joint filing with HighSage Ventures LLC (6.20%) | 5,394,779 | 7.30% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PPLI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,722,920 | 10.37% | $356.49M | −222,556 | 0.01% |
| Aristeia Capital LLC | 6,101,439 | 8.19% | $281.64M | +192,602 | 3.66% |
| Helikon Investments Ltd | 5,652,519 | 7.59% | $260.92M | +2,134,105 | 7.79% |
| Vanguard Portfolio Management LLC | 3,442,491 | 4.62% | $158.91M | −148,681 | 0.01% |
| Southeastern Asset Management Inc/Tn/ | 3,131,835 | 4.21% | $144.57M | −890,894 | 7.54% |
| Vanguard Capital Management LLC | 2,813,606 | 3.78% | $129.88M | −104,286 | 0.00% |
| Corvex Management LP | 2,793,715 | 3.75% | $128.96M | −561,360 | 3.94% |
| Aqr Capital Management LLC | 2,723,710 | 3.66% | $125.48M | +520,527 | 0.04% |
| Patient Capital Management, LLC | 2,425,558 | 3.26% | $111.96M | −274,006 | 3.67% |
| Davis Selected Advisers | 2,394,024 | 3.22% | $110.51M | −19,223 | 0.47% |
| State Street Corp | 2,159,770 | 2.90% | $99.69M | −95,517 | 0.00% |
| Goldman Sachs Group Inc | 1,463,438 | 1.97% | $67.55M | +968,441 | 0.01% |
| Foursixthree Capital LP | 1,342,201 | 1.80% | $61.96M | +1,067,551 | 12.78% |
| Geode Capital Management, LLC | 1,152,781 | 1.55% | $53.23M | −41,271 | 0.00% |
| Wallace Capital Management Inc. | 1,127,772 | 1.51% | $52.06M | +8,494 | 5.71% |
| Boston Partners | 1,111,298 | 1.49% | $51.29M | +237,959 | 0.05% |
| Thompson Siegel & Walmsley LLC | 1,063,090 | 1.43% | $49.07M | −757,979 | 0.88% |
| Morgan Stanley | 928,617 | 1.25% | $42.87M | +112,746 | 0.00% |
| Charles Schwab Investment Management Inc | 843,691 | 1.13% | $38.94M | −23,608 | 0.01% |
| Bank Of Montreal /Can/ | 825,380 | 1.11% | $38.27M | −1,212,444 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 339 | 69M | 92.6% | 58 / 98 | 118 / 46 | 9M | 10M |
| Q1 2026 | 332 | 70M | 94.6% | 44 / 122 | 108 / 58 | 14M | 7M |
| Q4 2025 | 352 | 71M | 95.5% | 68 / 95 | 143 / 54 | 15M | 14M |
| Q3 2025 | 343 | 73M | 98.7% | 50 / 121 | 114 / 48 | 11M | 10M |
| Q2 2025 | 342 | 72M | 97.0% | 63 / 103 | 120 / 54 | 13M | 9M |
| Q1 2025 | 334 | 69M | 92.7% | 50 / 113 | 108 / 63 | 8M | 8M |
| Q4 2024 | 353 | 69M | 93.3% | 55 / 107 | 126 / 60 | 8M | 13M |
| Q3 2024 | 366 | 75M | 100.0% | 54 / 116 | 122 / 38 | 11M | 7M |
| Q2 2024 | 356 | 79M | 100.0% | 71 / 118 | 95 / 74 | 13M | 8M |
| Q1 2024 | 362 | 74M | 100.0% | 50 / 131 | 101 / 35 | 6M | 6M |
| Q4 2023 | 351 | 74M | 98.8% | 54 / 84 | 154 / 56 | 12M | 6M |
| Q3 2023 | 355 | 68M | 91.7% | 39 / 105 | 139 / 50 | 7M | 8M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
230 funds held PPLI in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PPLI | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3,760,899 | 5.05% | $173.60M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,963,834 | 2.64% | $90.65M | 0.00% | Jun 30, 2026 |
| Longleaf Partners Fund | 1,688,257 | 2.27% | $77.93M | 7.35% | Jun 30, 2026 |
| Patient Opportunity Trust | 1,575,000 | 2.12% | $72.70M | 3.62% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,417,949 | 1.90% | $65.45M | 0.03% | Jun 30, 2026 |
| Davis New York Venture Fund | 1,125,830 | 1.51% | $46.80M | 0.61% | Jul 31, 2026 |
| Longleaf Partners Global Fund | 1,075,944 | 1.44% | $49.67M | 7.17% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 896,818 | 1.20% | $41.40M | 0.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 715,416 | 0.96% | $33.02M | 0.03% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 574,245 | 0.77% | $26.51M | 0.16% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 537,375 | 0.72% | $24.81M | 0.31% | Jun 30, 2026 |
| Allspring Special Small Cap Value Fund | 515,098 | 0.69% | $23.78M | 0.80% | Jun 30, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 444,929 | 0.60% | $20.54M | 0.18% | Jun 30, 2026 |
| First Trust Technology AlphaDEX Fund | 368,472 | 0.49% | $15.32M | 0.60% | Jul 31, 2026 |
| Column Small Cap Select Fund | 346,785 | 0.47% | $15.57M | 0.82% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Victor Kaufman | Vice Chairman, Director | 91,774 | 0.12% | Feb 11, 2026 |
| Barry Diller | Chairman & Senior Executive, Director | 801,945 | 1.08% | Nov 7, 2025 |
| Joseph Levin | Chief Executive Officer, Director | 199,433 | 0.27% | Jan 15, 2025 |
| Timothy Edward Quinn | Chief Financial Officer | – | – | Aug 17, 2026 |
| Neil Vogel | Chief Executive Officer | 9,941 | 0.01% | Aug 17, 2026 |
| Christopher Currier | See Remarks | 15,584 | 0.02% | Jun 26, 2026 |
| Michael H. Schwerdtman | SVP and CAO | 28,743 | 0.04% | Jun 1, 2026 |
| Christopher Halpin | EVP, CFO & COO | 137,757 | 0.18% | Feb 10, 2026 |
| Kendall Handler | EVP & CLO | 121,833 | 0.16% | Feb 10, 2026 |
| Michael D. Eisner | Director | 219,661 | 0.29% | Oct 2, 2026 |
| Chelsea Clinton | Director | 93,484 | 0.13% | Oct 2, 2026 |
| Bryan Lourd | Director | 204,637 | 0.27% | Oct 2, 2026 |
| Maria Seferian | Director | 12,431 | 0.02% | Oct 2, 2026 |
| Bonnie S. Hammer | Director | 40,669 | 0.05% | Jul 20, 2026 |
| Furstenberg Alexander Von | Director | 113,382 | 0.15% | Jul 20, 2026 |
| Alan G. Spoon | Director | 292,411 | 0.39% | Jul 20, 2026 |
| David S. Rosenblatt | Director | 97,261 | 0.13% | Jul 20, 2026 |
| Tor Braham | Director | 17,263 | 0.02% | Jul 20, 2026 |
| Richard F. Zannino | Director | 64,435 | 0.09% | Jul 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Bryan Lourd Director | Sep 30, 2026 | Award | +387 | $41.96 | $16.24K | 178,402 |
| Maria Seferian Director | Sep 30, 2026 | Award | +297 | $41.96 | $12.46K | 12,431 |
| Michael D. Eisner Director | Sep 30, 2026 | Award | +342 | $41.96 | $14.35K | 179,106 |
| Chelsea Clinton Director | Sep 30, 2026 | Award | +148 | $41.96 | $6.21K | 93,484 |
| Maria Seferian Director | Jun 30, 2026 | Award | +271 | $46.16 | $12.51K | 12,134 |
| Michael D. Eisner Director | Jun 30, 2026 | Award | +311 | $46.16 | $14.36K | 178,764 |
| Bryan Lourd Director | Jun 30, 2026 | Award | +352 | $46.16 | $16.25K | 204,250 |
| Chelsea Clinton Director | Jun 30, 2026 | Award | +135 | $46.16 | $6.23K | 93,336 |
| Furstenberg Alexander Von Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 113,382 |
| Tor Braham Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 17,263 |
| David S. Rosenblatt Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 97,261 |
| Richard F. Zannino Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 64,435 |
| Chelsea Clinton Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 93,201 |
| Michael D. Eisner Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 178,453 |
| Maria Seferian Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 11,863 |
| Bryan Lourd Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 203,898 |
| Alan G. Spoon Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 277,411 |
| Bonnie S. Hammer Director | Jun 18, 2026 | Option exercise | +2,263 | – | – | 40,669 |
| Bonnie S. Hammer Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 38,406 |
| Furstenberg Alexander Von Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 111,119 |
| Bryan Lourd Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 201,635 |
| Michael D. Eisner Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 176,190 |
| Richard F. Zannino Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 62,172 |
| Chelsea Clinton Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 90,938 |
| David S. Rosenblatt Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 94,998 |
| Alan G. Spoon Director | Jun 15, 2026 | Option exercise | +1,609 | – | – | 275,148 |
| Richard F. Zannino Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 60,563 |
| Bryan Lourd Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 200,026 |
| Maria Seferian Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 9,600 |
| David S. Rosenblatt Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 87,832 |
| Michael D. Eisner Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 174,581 |
| Furstenberg Alexander Von Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 105,786 |
| Bonnie S. Hammer Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 36,797 |
| Chelsea Clinton Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 89,329 |
| Alan G. Spoon Director | Jun 11, 2026 | Option exercise | +2,076 | – | – | 244,505 |
| Michael H. Schwerdtman SVP and CAO | May 12, 2026 | Sale | −6,878 | $40.54 | $278.83K | 28,743 |
| Michael D. Eisner Director | Mar 31, 2026 | Award | +359 | $40.03 | $14.37K | 172,505 |
| Bryan Lourd Director | Mar 31, 2026 | Award | +406 | $40.03 | $16.25K | 197,950 |
| Maria Seferian Director | Mar 31, 2026 | Award | +312 | $40.03 | $12.49K | 7,524 |
| Chelsea Clinton Director | Mar 31, 2026 | Award | +156 | $40.03 | $6.24K | 87,253 |
| Michael H. Schwerdtman SVP and CAO | Feb 28, 2026 | Option exercise | +11,262 | – | – | 40,005 |
| Michael H. Schwerdtman SVP and CAO | Feb 28, 2026 | Tax withholding | −4,384 | $38.32 | $167.99K | 35,621 |
| Victor Kaufman Vice Chairman, Director | Feb 10, 2026 | Option exercise | +2,445 | – | – | 23,490 |
| Victor Kaufman Vice Chairman, Director | Feb 10, 2026 | Tax withholding | −1,007 | $36.47 | $36.73K | 22,483 |
| Christopher Halpin EVP, CFO & COO | Feb 8, 2026 | Tax withholding | −11,668 | $35.65 | $415.96K | 137,757 |
| Christopher Halpin EVP, CFO & COO | Feb 8, 2026 | Option exercise | +22,855 | – | – | 149,425 |
| Kendall Handler EVP & CLO | Feb 8, 2026 | Option exercise | +28,568 | – | – | 121,833 |
| Kendall Handler EVP & CLO | Feb 8, 2026 | Tax withholding | −14,584 | $35.65 | $519.92K | 107,249 |
| Christopher Halpin EVP, CFO & COO | Feb 6, 2026 | Option exercise | +84,937 | – | – | 169,931 |
| Christopher Halpin EVP, CFO & COO | Feb 6, 2026 | Tax withholding | −20,931 | $35.65 | $746.19K | 84,994 |
| Christopher Halpin EVP, CFO & COO | Feb 6, 2026 | Option exercise | +40,716 | – | – | 105,925 |
| Christopher Halpin EVP, CFO & COO | Feb 6, 2026 | Tax withholding | −43,361 | $35.65 | $1.55M | 126,570 |
| Kendall Handler EVP & CLO | Feb 6, 2026 | Option exercise | +43,042 | – | – | 115,429 |
| Kendall Handler EVP & CLO | Feb 6, 2026 | Tax withholding | −22,164 | $35.65 | $790.15K | 93,265 |
| Kendall Handler EVP & CLO | Feb 6, 2026 | Tax withholding | −9,898 | $35.65 | $352.86K | 72,387 |
| Kendall Handler EVP & CLO | Feb 6, 2026 | Option exercise | +19,388 | – | – | 82,285 |
| Chelsea Clinton Director | Dec 31, 2025 | Award | +160 | $39.10 | $6.26K | 87,097 |
| Maria Seferian Director | Dec 31, 2025 | Award | +320 | $39.10 | $12.51K | 7,212 |
| Bryan Lourd Director | Dec 31, 2025 | Award | +416 | $39.10 | $16.27K | 197,544 |
| Michael D. Eisner Director | Dec 31, 2025 | Award | +368 | $39.10 | $14.39K | 172,146 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 5 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of People's stock actually held short. Settlement fails (shares not delivered on time) peaked at 30,911 shares on Sep 25, 2026 over the last 90 days.
See a number that looks wrong?